Melatonin in Autism Spectrum Disorders

By  

Current Clinical Pharmacology, Vol. 9, Iss. 4, 2014-11 ,pp. : 326-334

Bentham Science Publishers

Access to resources Recommend Favorite

Potential for Early-Life Immune Insult Including Developmental Immunotoxicity in Autism and Autism Spectrum Disorders: Focus on Critical Windows of Immune Vulnerability

By Dietert Rodney  

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 11, Iss. 8, 2008-10 ,pp. : 660-680

Taylor & Francis Ltd

Access to resources Recommend Favorite

Mitochondrial Dysfunction and Its Relationship with mTOR Signaling and Oxidative Damage in Autism Spectrum Disorders

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 5, 2015-08 ,pp. : 373-389

Bentham Science Publishers

Access to resources Recommend Favorite

Neuro-Inflammatory Mechanisms in Developmental Disorders Associated with Intellectual Disability and Autism Spectrum Disorder: A Neuro- Immune Perspective

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 4, 2016-05 ,pp. : 448-463

Bentham Science Publishers

Access to resources Recommend Favorite

The status of pharmacotherapy for autism spectrum disorders

By Myers Scott M  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 11, 2007-08 ,pp. : 1579-1603

Informa Healthcare

Access to resources Recommend Favorite